George Washington University and Curative to Deploy COVID Testing for U.S. Troops

Agreement Provides New On-site Curative COVID-19 Testing for U.S. Air Force
George Washington University

Newswise — WASHINGTON, DC (April 29, 2020) – The George Washington University Milken Institute School of Public Health (GW Milken Institute SPH) today announced signing an agreement with Curative, Inc. to provide laboratory space for the company to start testing U.S. military personnel for the virus that causes COVID-19. The testing, conducted by Curative in the GW Milken Institute SPH Biosafety Level 2 Laboratory (BSL-2), will help scientists understand the spread of the virus, help the U.S. military maintain readiness, and ultimately will help with reopening the economy.

Curative will begin processing up to 50,000 tests per day in the GW BSL-2 lab as part of an agreement it recently signed with the U.S. Air Force. The U.S. Air Force will deploy test kits to military personnel and train them to perform a simple swab for oral fluids. Curative’s test kit, which was authorized by the U.S. Food and Drug Administration, is a simple-to-use oral swab test that does not create exposure for healthcare workers during sample collection.

 “We are proud to be a part of this partnership to launch testing of U.S. military personnel for the virus that causes COVID-19,” said GW President Thomas J. LeBlanc. “Our BSL-2 laboratory offers a secure environment in order to process the tests, which will offer valuable information in the fight against this virus.”

Curative will conduct this work in the GW Milken Institute SPH BSL-2 and additional space provided by the GW Department of Anthropology, all located in the GW Science and Engineering Hall, which is equipped with state-of the-art laboratories and equipment.

Curative has tested more than 100,000 people for COVID-19 and is currently processing about 6,000 tests per day for residents of Los Angeles. The test kits include a swab for collecting oral fluids from the inside of the mouth. The military will then send the samples, which contain deactivated virus, to the laboratory at GW Milken Institute SPH for testing with polymerase chain reaction. Test results will be available within 24 hours.

The agreement between Curative and the U.S. Air Force includes the cost of building more than 40,000 test kits and training military troops to perform the easy-to-use swabs. If the initial launch shows the testing can be ramped up, Curative will establish eight additional testing locations across the United States to support testing of the U.S. population. The Curative test kits are considered lower risk than deep nasal swabs, which can deplete scarce personal protective equipment and can potentially expose healthcare workers to the virus.

Curative is a California-based company founded in January to test for life-threatening blood infections called sepsis. The start-up shifted gears in response to the COVID pandemic and has redirected its manpower to help the nation conduct COVID testing.

“We will not make progress toward bringing our economy back online until we have comprehensive testing across the United States, and that means we need easy to administer, highly scalable tests now,” said Fred Turner, CEO, Curative. “We’re proud to be working with the U.S. military and GW Milken Institute SPH to demonstrate just how rapidly we can scale our oral fluid test. We look forward to partnering with other universities across the country as we bring this test to our global Armed Forces and beyond.”

The GW Milken Institute SPH BSL-2 laboratory and additional space, located just a few miles from the Pentagon and many federal office buildings, offers an ideal location for this unique partnership to power up the U.S. response to the COVID pandemic.

“The United States must expand testing for COVID-19 in order to both contain and ultimately defeat this virus,” said Lynn Goldman, MD, MS, MPH, the Michael and Lori Milken Dean of the GW Milken Institute SPH. “This partnership holds out the promise of widespread testing in the United States, which will provide us with the information we need to keep our troops and the general population safe.”

Filters close

Showing results

1120 of 3821
Newswise: UNH Digs Deep Testing Wastewater for Early Warning Signs of COVID-19
Released: 28-Oct-2020 1:05 PM EDT
UNH Digs Deep Testing Wastewater for Early Warning Signs of COVID-19
University of New Hampshire

The University of New Hampshire has gone underground to flush out cases of the coronavirus by testing wastewater on campus. The sewage sampling is being used as a secondary surveillance method to the already required twice a week individual nasal test to track and detect SARS-CoV-2, the virus that causes COVID-19.

Newswise: Safely Celebrate the Holidays During COVID-19
Released: 28-Oct-2020 12:50 PM EDT
Safely Celebrate the Holidays During COVID-19
Rush University Medical Center

Families gathered around the table for hours to share food, conversation and laughter — all the ingredients for a joyous holiday -- and the spread of COVID-19. Rush infectious disease specialists and a child psychologist share facts and tips for enjoying the holidays safely.

Released: 28-Oct-2020 12:45 PM EDT
COVID-19 vaccine nationalism could cost world up to $1.2 trillion: New RAND Europe study
RAND Corporation

Nationalistic behaviour by governments may exclude some countries from gaining access to COVID-19 vaccines and cost the global economy up to $1.2 trillion a year in GDP, according to a new study from the not-for-profit research organisation RAND Europe.

Newswise:Video Embedded first-came-breast-cancer-then-covid-19
Released: 28-Oct-2020 12:00 PM EDT
First Came Breast Cancer, Then COVID-19

Natalie Coehlo wasn’t concerned at first about the sudden rash on her left breast last December. Six months later, though, when the rash had morphed into sores, she visited her primary care physician in Tulare, California.

Newswise: 247119_web.jpg
Released: 28-Oct-2020 11:55 AM EDT
Lockdown interviews show poor housing quality has made life even tougher
University of Huddersfield

Life during COVID-19 has not been a uniform experience. There have been distinct differences in how people have contended with lockdown, depending on whether they have access to safe, secure and decent accommodation.

Released: 28-Oct-2020 11:45 AM EDT
Cognitive disorders linked to severe COVID-19 risk
University of Georgia

Dementia and other cognitive disorders now appear to be risk factors for developing severe COVID-19, according to research from the University of Georgia.

Newswise: University of Miami serving as pilot study site for new, rapid coronavirus breathalyzer test
Released: 28-Oct-2020 11:40 AM EDT
University of Miami serving as pilot study site for new, rapid coronavirus breathalyzer test
University of Miami Health System, Miller School of Medicine

By participating in a short clinical research study that begins this week, the University of Miami became the first college testing site for a quick, easy, and cost-effective Israeli-produced COVID-19 Breath Analyzer that could revolutionize coronavirus testing if approved by the U.S. Food and Drug Administration (FDA).

Newswise: UB spinoff Cytocybernetics receives funding to accelerate COVID-19 drug screening
Released: 28-Oct-2020 11:35 AM EDT
UB spinoff Cytocybernetics receives funding to accelerate COVID-19 drug screening
University at Buffalo

University at Buffalo spinoff Cytocybernetics is developing a high-tech tool called CyberQ to rapidly assess whether or not investigational COVID-19 drugs have arrhythmogenic properties that can result in sudden cardiac death.

Newswise: Nova Southeastern University Researchers Receive $4 Million From CDC for ‘COVID Long Haulers’ Study
Released: 28-Oct-2020 11:30 AM EDT
Nova Southeastern University Researchers Receive $4 Million From CDC for ‘COVID Long Haulers’ Study
Nova Southeastern University

As the COVID-19 pandemic continues to evolve, health care providers are finding more and more patients are experiencing lingering symptoms after recovering from the virus. While the medical community is still working hard to address the virus itself and racing toward a vaccine, there is very little known or being done to address these residual health issues being experienced by those now called “COVID long haulers.” But all of that is about to change, thanks to research scientists at Nova Southeastern University (NSU.)

Showing results

1120 of 3821